Professor Richard F. Lockey, M.D., M.S., received his B.S. degree from Haverford College, Haverford, Pennsylvania; M.D. from Temple University, Philadelphia, Pennsylvania (Alpha Omega Alpha); M.S. from the University of Michigan in Ann Arbor, Michigan, where he trained in Internal Medicine and Allergy/Immunology (A/I); he was a Major in the US Air Force and Chief of A/I at Carswell Air Force Base, Fort Worth, Texas, from 1970-1972. His academic titles include Distinguished University Health Professor; the Joy McCann Culverhouse Chair of Allergy and Immunology; Professor of Medicine, Pediatrics and Public Health; and Director, Division of Allergy and Immunology, Department of Internal Medicine, University of South Florida Morsani College of Medicine. Professional honors include President of the American Academy of Allergy Asthma and Immunology (1992), past Director of the American Board of Allergy and Immunology (1993- 1998), and President of the World Allergy Organization (2010-2012). He has also served as co-editor or participant of two World Health Organization reports, the most important of which is the 1998-1999 WHO Position Paper Allergen Immunotherapy: Therapeutic Vaccines for Allergic Diseases. He serves or has served on a variety of different journal editorial boards and was instrumental in democratizing the American Academy of Allergy Asthma and Immunology and the World Allergy Organization. The Division of Allergy and Immunology, Department of Internal Medicine, was selected as a World Allergy Organization (WAO) Center of Excellence for the 2016-2019 term, and subsequently until 2026 under his leadership. He has the honor of authoring or co-authoring over 900 publications, has edited or co-edited 20 monographs and 21 books, and has lectured extensively both nationally and internationally. He is the co-editor, with Dennis K. Ledford, MD, of the 6th edition of Allergens and Allergen Immunotherapy: Subcutaneous, Sublingual and Oral, published in 2020 by the CRC Press/Taylor & Francis Group. Over 100 physician specialists and 55 international post-graduate PhDs or MDs in basic and clinical research and medicine, many of whom have assumed leadership positions throughout the world, have been trained in the Division. The Division's staff consists of 7 clinicians, 4 basic scientists, and approximately 60 other healthcare professionals including physicians and support and laboratory personnel. Areas of expertise and research include insect allergy, allergen immunotherapy, asthma, inflammatory lung diseases, pulmonary fibrosis, co-morbid conditions of asthma, food allergy, hereditary angioedema, atopic eczema, finding better ways to administer epinephrine, and idiopathic urticaria and angioedema.